22% (6,785) of veterinary surgeons eligible to vote did so, compared to the previous record of 18.8%.
The votes were as follows:
For the two places available on VN Council one new member was elected and one existing member re-elected for four year terms. Andrea Jeffery was re-elected with 1,293 votes, while Susan Howarth was elected with 1,064 votes.
Eleanor Ferguson, RCVS Registrar, said: "Congratulations to all those elected to RCVS Council and VN Council and thank you to all those who stood as candidates in both elections.
"We would especially like to thank Jerry Davies, Peter Jinman and Bradley Viner who are standing down from RCVS Council this year after deciding not to seek re-election, in addition to Chris Gray and Tom Witte for their contributions to RCVS Council and Marie Rippingale for her contribution to VN Council.
"Thank you also to all those who took the time to ask questions of our candidates and cast a vote. This year we made a concerted attempt to make it even easier for the electorate to vote, with secure links to the voting websites sent by email and regular email reminders to those who hadn’t yet voted. The fact that both record numbers and proportions of the professions voted this year is testament to our efforts to further increase engagement with veterinary surgeons and veterinary nurses.
"However, while we welcome these significant increases, we recognise that it is still a relatively small proportion of the profession voting in these elections and so will continue to think of new ways to engage with the professions not just at election time, but across our many activities."
All the successful candidates will take up their positions at RCVS Day – the College’s Annual General Meeting and Awards Day – on Friday 7 July 2017 at the Royal Institute of British Architects where the formal declaration of both election results will also take place.
Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis as well as to reduce post-surgical soft tissue reaction.
The new apple-flavoured version, which contains no added sugar, is presented in 1.5g sachets which are added to feed. The existing unflavoured product is still available as Equipalazone Original.
Dechra Brand Manager Emma Jennings said: “The new apple flavoured Equipalazone is the same tried and trusted popular product that vets have been using for many years but the enhanced apple flavour should improve compliance amongst even the fussiest of feeders.
"Equipalazone has been a best-selling treatment delivering powerful pain relief since we brought it to the market as the first microencapsulated phenylbutazone more than 45 years ago. The new apple flavoured presentation will give vets even more choice when it comes to providing pain relief and anti-inflammatory treatment for equine conditions."
For more information visit www.dechra.co.uk.
The new presentation is honey-flavoured and is available in 30ml or 100ml bottles with a syringe for precise dosing.
It has a two-year shelf life and a broached shelf life of six months.
Dechra companion animal brand manager, Thomas Johnson, said: “The addition of Felimazole Oral to our product range will provide vets with the flexibility to prescribe Felimazole as either a tablet or oral solution to accommodate the preferences of both the cat and its owner.
"This, combined with our extensive endocrinology resources, will ensure that vets have all the necessary tools to support their feline hyperthyroid cases.”
https://www.dechra.co.uk/cushings-connect
https://www.dechra.co.uk/addisons-connect
https://www.dechra.co.uk/search?q=felimazole#/search=Felimazole
https://apps.apple.com/gb/app/dechra-endocrinology-app/id1660737534
The survey is part of an initiative to develop a 'roadmap' for what needs to happen to support veterinary teams to deliver contextualised care and shared decision-making.
The survey will be used alongside interviews with people in a range of roles in the veterinary sector, including veterinary receptionists and practice managers, to gather insights about what makes it easier or more difficult to practise contextualised care and what could help support its delivery.
Pet owners will also be surveyed and invited to focus groups to understand what matters most to them when making decisions about their pets’ health, and what would help them to feel supported to decide the veterinary care that is right for them and their pet.
Sally Everitt, Clinical Lead – Evidence at RCVS Knowledge, said: “Although the term contextualised care is now being widely used, and a requirement to practise contextualised care is included in the RCVS Guidance for veterinary surgeons and veterinary nurses, there is little information available on how contextualised care is most effectively delivered in practice.
"Our research aims to address a gap in the evidence about what the barriers and enablers are and what needs to change to support veterinary teams to deliver contextualised care.”
The survey is open to veterinary surgeons currently in clinical practice in the UK working with dogs and cats.
The survey can be accessed here until 17th April 2025: https://survey.alchemer.eu/s3/90806393/rcvskresearchprofessionals
Photo: www.depositphotos.com
Mr Ng faced seven charges:
Mr Ng admitted some aspects of the charges against him, including that he had deleted two patient records and that this was dishonest and misleading.
The Committee then determined the facts of the rest of the charges after hearing evidence from witnesses and Mr Ng himself, as well as expert witnesses.
Having considered all the evidence, it determined which elements of the charges were proved, and which were not.
The Committee then considered whether the admitted and charges found proved amounted to serious professional misconduct.
In doing so it considered that the charges against Mr Ng fell into three broad categories – deficiencies in clinical care, deficiencies in record keeping, and dishonesty.
In respect of all three, it found the admitted and charges found proved amounted to serious professional misconduct.
In terms of aggravating factors, the Committee found that Mr Ng’s conduct had directly caused harm to animals and also created risk of further harm, and noted that there were three instances of dishonesty.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee noted that there were three instances of dishonest behaviour in relation to clinical records.
"The amendment of the clinical record in the labradoodle’s case was particularly serious.
"This alteration was made at a time when the respondent knew that the owner was dissatisfied with the treatment the dog had received and was complaining about the lack of therapeutic intervention.
"The alteration presented a false account of the owner’s attitude towards immediate therapeutic intervention.
"Conduct of this kind was liable to damage trust in the profession.”
In mitigation, the Committee took into account the sense of pressure Mr Ng felt following a financial dispute with his relative in respect of the veterinary practice, his long career as a veterinary surgeon and the high regard with which he was held by those who provided testimonials on his behalf.
The Committee acknowledged Mr Ng’s assertions that he now understood his failings and his expressions of remorse for the harm he had caused and that these indicated the beginnings of insight.
However, in respect of the clinical deficiencies, the Committee found that various aspects of Mr Ng’s approach to treating conditions such as diabetes and cherry eye were inadequate and out-of-date, and that there was little in his continuing professional development (CPD) record or his statements to suggest he had attempted to improve these deficiencies.
Ultimately, the Committee found that Mr Ng’s conduct was so serious that removal from the Register was the most appropriate sanction.
Paul Morris added: “The Committee has concluded that the respondent’s behaviour was fundamentally incompatible with being a veterinary surgeon.
"In view of the nature and gravity of the Committee’s findings in this case, removal from the Register is necessary to ensure the protection of animals and the maintenance of public confidence in the profession and the regulatory process.”
www.rcvs.org.uk/disciplinary
The company says the aim is to identify the most effective ways to minimise the risks this common and debilitating infectious equine virus poses. The survey can be found here.
Equine Herpes Virus is a contagious virus, which can cause respiratory disease, abortion and more rarely neurological disease. In addition, sub-clinical infections can be associated with a syndrome of poor performance and have a potential effect on the health of the whole yard.1
The disease is transmitted from horse to horse through the respiratory tract, by inhalation of the viral particles shed by infected horses. Once a horse is infected with Equine Herpes Virus it is likely to be latently infected for life. Viral reactivation and nasal shedding can occur at any time, particularly during stressful periods such as when mixing with other horses at equine events. This can lead to acute disease episodes. Often affected horses are asymptomatic but if they do show symptoms these may include depression, lethargy, pyrexia, nasal discharge and a dry cough. Reduction of shedding through management and vaccination is key to disease control.2
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "EHV has potentially serious health, performance and financial implications across every sector of the equestrian industry.
"The aim of our survey is to find out more about current vet protocols in practice. The results should help us to identify and then ensure that the most effective prevention strategies are accessible to vets and their clients."
The survey runs from 4 – 22nd March 2019 in parallel to a separate survey for horse owners.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
References
532 veterinary practices responded to the survey, which was sent to 3,096 veterinary practices for which the RCVS had a unique email address, on 3rd April.
The survey found that:
Three-quarters of those who responded to the survey answered a question on how the RCVS could better support veterinary practices through the crisis. The most frequent response (27%) was that the RCVS needed to provide clearer guidance, in particular as to what services it was permissible for veterinary practices to provide [the College published its updated guidance and flowchart on 9 April].
Of those who responded to the question, 15% felt that the RCVS was doing a good job or that there was nothing more it should do, while just 2% of responses expressed negative sentiment towards the RCVS.
Lizzie Lockett, RCVS Chief Executive, said: “I would like to thank all those practices who took the time in what is already a very fraught situation to respond to our survey and provide the evidence we need to gain a holistic picture of coronavirus’ impact on the business and economics of veterinary practices. We plan to continue running these surveys on a regular basis in order to gauge impact over time and the findings will feed into our policy and decision-making.
"This ongoing research will also be a vital tool when we are talking to Government and other bodies about the impact of policy on the veterinary sector. On this note, we are aware of the challenges of a minimum furlough period of three weeks given the need for practices to take steps to offer 24/7 emergency and critical care, and have written to government on this with some case studies around the impact this is having.
"To those on the ground it won’t come as too much of a surprise that the impact of the coronavirus has been profound in areas such as practice turnover and staffing, with many vets, veterinary nurses and other support staff being furloughed with the aim of signing them up to the Government’s Coronavirus Job Retention Scheme.
"There are some bright spots in the data we’ve gathered – very few practices reported that they had made or were planning to make staff redundant, and many practices reported mitigating the challenge of social distancing by carrying out consultations with new and existing clients remotely.
"Since the survey took place we have also taken steps to meet some of the requests for greater clarity and guidance from the RCVS with the publication of our flowchart helping practices to decide what treatments it is appropriate to carry out safely amidst the COVID-19 pandemic."
The survey results can be read in full at www.rcvs.org.uk/publications.
The next practice impact survey is planned for early May.
Faecal matter transplantation (FMT) has been used in people to treat Clostridium difficile infections and has also been trialled in conditions such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis.
The researchers believe that FMT offers a potential new option for the treatment of chronic diarrhoea in dogs and the study will investigate whether it contributes to a more rapid resolution of clinical signs. The study is being conducted in association with eight other private practices or universities around the country.
Julien Bazelle, a European Veterinary Specialist in Small Animal Internal Medicine at Davies said: "The goal is to recruit, over a short period of time, canine patients with chronic small intestinal diarrhoea, for a randomised trial in which the cohort receives or not FMT at the time of the initial investigations and prior to any other treatment.”
Dogs aged 6 months to 10 years with a history of chronic small intestinal diarrhoea (+/- other GI signs) are needed to participate in the study. Half of the dogs will receive FMT and the other half will be managed without. FMT will be performed in eligible patients during the sedation for their routine abdominal ultrasound. Transplanted faecal matter will be administered via a retention enema.
To be eligible, dogs must not have received antibiotics, probiotics or steroids recently.
If you have a potentially suitable patient please contact: julien.bazelle@vetspecialists.co.uk or Fergus.Allerton@willows.uk.net
Royal Canin has announced the launch of a summer campaign to help small animal practices develop their relationships with cat-owning clients.
'Summer of the Cat' runs throughout July, August and September. As part of the campaign, cat owners are being invited to share adventures their cat has over the summer with their vet practice, for the chance to win a year's supply of Royal Canin cat food.
Entry forms, which contain spaces for photos and drawings, will be distributed to practices along with other promotional materials such as balloons, posters, bunting, tent cards and wobblers.
The competition - which also gives entrants the chance to win large A3 posters of their 'Summer of the Cat' storyboards - is being supported by a promotional offer to 'feed your cat free for a week' from July to September.
Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers will be able to buy any 1.5 - 2kg bag of feline Veterinary Care Nutrition from their vet and get a 400g bag free. Those cat owners taking up the offer will also receive a money off voucher (£3/€4) for their next purchase to encourage loyalty and increased footfall in the participating vet practices."
For more information, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.
Undertaken in practice, industry and academia, submissions are open each year offering the chance to present a Clinical Abstract, presented as a poster or an oral presentation.
Christine Pye won the Medicine Award for her longitudinal study of age, sex and health-related changes in physical biomarkers in pet cats
Alberto Sesana won the Surgery Award for his abstract: "Outcome of lip-to-lid subdermal plexus flaps to reconstruct defects of the lower eyelid in dogs and cats: 46 cases (2005-2022)."
Deborah Komianos won the Practitioner Award for "Reducing use of critically important antibiotics: A clinician-led improvement project across 21 UK small animal veterinary practices."
Rosemary Perkins won the Poster Award for: "Swimming emissions from dogs treated with spot-on fipronil and imidacloprid: assessing the environmental risk."
Lastly but not leastly, Claudia Franzini won the Student Award for: "Does the surgical method for management of Cranial Cruciate Ligament Rupture in dogs affect clinical outcome?"
Submissions for the 2026 Clinical Abstracts will open on 8th September 2025.
https://www.bsavacongress.com
Photo: L-R, Alberto Sesana, Deborah Komianos, Christine Pye, Rosemary Perkins, Claudia Franzini
The practical, wet lab, small group and 'Breakfast with a Specialist' programme has expanded to enhance the CPD experience and to meet rising demand, alongside more than 450 lectures for delegates to choose from.
Wet lab sessions, introduced at Congress 2017, will again be held at the University of Birmingham’s Medical School and include topics on cytology, haematology, basic eye surgery, rabbit dentistry and dental radiography for dogs and cats.
'Breakfast with a Specialist' sessions give delegates exclusive access to world-renowned experts to discuss challenging cases informally, in a small group setting: endocrinology cases with David Church on Friday, epilepsy cases with Holger Volk on Saturday and jaw fracture fixation in the dog and cat with Peter Southerden on Sunday.
BSAVA Congress Programme Committee Chair Sue Murphy said: "Responding to the excellent delegate feedback from 2017’s programme, we are increasing the number of practical and small group sessions to enable more delegates to benefit in 2018. These sessions represent excellent, value for money education and a unique opportunity for delegates to practice vital skills with guidance from experts in their respective disciplines.’"
Each workshop or small group is available to purchase when registering for Congress and a full summary of each practical and small group session is available at: http://www.bsavacongress.com/programme
The 61st annual BSAVA Congress takes place at the Birmingham ICC and Arena Birmingham from 5-8 April, including a new non-clinical stream on Sunday – Beyond the Clinics.
The Executors of the Will of the late Mary Brancker have notified the Veterinary Benevolent Fund that she left a share of her estate to the charity.
Mary Brancker was one of only a handful of women vets when she qualified in 1937. She went on to found the Society of Women Veterinary Surgeons; became one of the first women on BVA Council and was later awarded an OBE for her services as BVA President during the century's most serious outbreaks of foot-and-mouth disease and a CBE in 2000 for services to animal health and welfare.
Mary was a long-time member of the VBF - a charity that has been run by vets for the profession for over a hundred years.
The VBF currently provides the Vet Helpline, the Veterinary Benevolent Fund, the Veterinary Surgeons' Health Support Programme and the Vetlife website. The charity says it plans to use Brancker's £40,000 bequest specifically for the redevelopment of the Vetlife website which is currently underway and for other essential support for veterinary colleagues in need. The new version of the website will be launched at the London Vet Show in November.
VBF's President Lydia Brown said: "Mary was a personal friend and her gift is so typical of her kindness and her appreciation of her career. I hope others will follow Mary's wonderful example and consider giving generously to VBF. A legacy is of enormous benefit to our charity and the veterinary profession as a whole. Although we are making every effort to adapt to the changing needs of the profession there is always more that can be done if we have sufficient funding."
Veterinary Benevolent Fund T: 020 7908 6385E: info@vetlife.org.uk
Veterinary Surgeons' Health Support ProgrammeT: 07946 634220E: VSHSP@vetlife.org.uk
Vet HelplineT: 07659 811118
See www.vetlife.org.uk for more information. Donations can be made to VBF on-line at www.virginmoneygiving.com
Royal Canin has launched a range of new renal diets to help support cats and dogs with Chronic Kidney Disease (CKD).
According to the company, CKD patients are twice as likely to show signs of anorexia, food intolerance and loss of appetite than non-CKD pets, so the focus with the new diets has been on different aromatic profiles, textures and tastes to provide choice and encourage feeding without compromising the nutritional management of the pets with CKD.
Royal Canin says each of the diets in the new Renal range has been developed with a unique aromatic profile, so that cats and dogs can be attracted to their food bowl even after an episode of food aversion.
The new range also provides two different textures of dry diet for both cats and dogs. In addition to the classic kibbles found in Renal and Renal Special, the new Renal Select diet for cats has a pillow kibble with a thin, crunchy shell and a soft centre for cats who used to love crunching but are beginning to struggle with harder kibbles. The new kibbles for dogs are designed to be easy to rehydrate, providing the taste of a dry diet in a softer, easier to chew format. A new Renal Wet range is also available with a 'loaf' or 'chunks-in-gravy' texture and these can be combined with any dry diet to allow even greater variety of textures.
With CKD causing frequent fluctuations in an animal's sense of taste, Royal Canin has made the feline range available in smaller 500g bags, making it easier for owners to swap between the differing options as their pet's tastes alter.
Royal Canin's Veterinary Marketing Manager, Marianne Lomberg, said: "The efficiency of a renal diet depends upon it being fed on a continuing basis and so our new range provides a complete range of aromatic profiles and textures to keep your CKD patients enjoying every meal without compromising on their nutritional management. Royal Canin has a proven track record of developing innovative diets to help pets, and the new Renal Diets are an exciting new move for us."
Royal Canin is also offering a 'patient compliance guarantee' where vets and their clients can claim their money back if a pet does not like any of the many diet combinations offered by the range.
Practices which want to buy the alternative imported vaccine will need to apply to the VMD for a Special Import Certificate (SIC).
Wholesalers have agreed to stock the alternative vaccine.
Zoetis says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working hard to resume Equip Rotavirus supply as soon as possible.
For further information, contact your Zoetis account manager or ring Zoetis HQ on 0345 300 8034.
Kaminox contains potassium gluconate and B-vitamins to help dogs affected by hypokalaemia.
Originally released as an oral liquid supplement, Vetplus says this new powdered formulation offers a more concentrated level of potassium for larger pets or those that require a higher dose.
Kaminox sachets are sold in packs of 30, with a scoop provided for easy administration.
Meanwhile, the liquid supplement is available in 60ml and 120ml bottles.
www.vetplus.co.uk/products
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
VetSurgeon.org member Sam Westhead, a vet from Farnborough, has secured sponsorship from Vets Now and Vet Times in his entry to the grueling Ironman 70.3 World Championship challenge in Clearwater in Florida this November
The two organisations will each sponsor Sam £250 for taking part in the challenge.
Sam, who works at Grazely Vets in Farnborough, qualified for the World Championship event earlier this year in the Singapore Ironman 70.3, coming first in the veterans group and a not too shabby 30th overall!
Clearly not for the faint hearted, the Ironman 70.3 World Championship consists of a 1.2 mile swim, a 56-mile bike and a 13.1 mile run, adding up to 70.3 miles of total racing.
Speaking about his entry to the race, Sam commented; "The training is going well and I'm trying to focus on keeping up the momentum and enthusiasm for the race as the countdown is now on! I'm obviously looking forward enormously to arriving in Florida in a few weeks time and competing in the event - it's a real achievement to have got to this stage. I would like to say a big thank you to Vets Now and the Vet Times for their extremely kind donations which will go some way to covering the cost of my flights to and from the event."
Richard Dixon, Group Managing Director for Vets Now said; "Sam is an extremely dynamic individual who displays wonderful passion for both his career and in living life to the full. I know he has trained hard to qualify for the event and to get to this stage and Vets Now is delighted to be backing Sam in this particularly grueling and ambitious challenge. We wish him well in his final few weeks of training and of course in the event in November."
Organisers of The London Vet Show 2009 report that the event was a great sucess, greeted with 'considerable delight' by delegates and exhibitors alike.
The event, which featured clinical and commercial lectures as well as a major exhibition, ran on 6th and 7th November at London's Olympia Conference Centre. 2410 veterinary professionals attended, and most were there for both days.
VetSurgeon.org attended the event, asking commercial exhibitors: "What's New?" Those of you that didn't make it to the show can click here to watch a video of their answers.
Overall feedback from vets about the quality of the CPD programme was overwhelmingly positive. Delegate feedback forms rated the quality of speakers in the programme as 4.39 out of 5, and rated the event as 4.68 out of 5 in terms of value for money.
Rachel Bolus of Riverside Veterinary Practice said: "All the lectures were to a really good standard - a lot of CPD for a very cheap price."
Bridget O'Farrell of Dick Vet Small Animal Practice agreed: "Very cheap for two days of CPD and the quality of the speakers has been very good. I went to five lectures yesterday and planning on six today. It's been a very worthwhile exercise and I would certainly recommend this to my peers".
Event organiser Phil Nelson said: "We have witnessed an amazing two days, surpassing all delegate estimates and it's gone down really well. The 2010 exhibition is already 40% bigger than this year almost 12 months out and looks set to sell out. We are carefully listening to the delegates and exhibitors comments, and have already a number of plans to develop and build the event going forward. But as a starting point we could never have dreamt for the launch event to be so well received."
For 2010 the London Vet Show is moving to the bigger Olympia National Hall having out grown the Conference Centre. It will run on October 22nd and 23rd. It is committed to retaining the same approach to offering affordable and World Class CPD qualifying clinical and commercial content for all the UKs vets. Having very quickly established itself as a major part of the veterinary calendar the organisers expect to announce their 2010 programme in the early part of 2010.
The Disciplinary Committee of the Royal College of Veterinary Surgeons has directed that the name of a veterinary surgeon who had been practising in Essex be removed from the RCVS Register, having found him guilty of attempting to obtain medicines dishonestly.
James Alexander Lockyear, a graduate from Pretoria University in South Africa, was charged with two offences. The case was heard in his absence, although the Committee did not draw any adverse inference from this. One charge concerned his attempted purchase of steroids from a pharmacy in Colchester by dishonestly representing that the medicine was for legitimate veterinary use. The second charge related to several instances of what the Committee referred to as "inappropriate and unprofessional behaviour", including showing an offensive image to another staff member on a mobile phone, placing the testicle of a castrated dog in his mouth and the misuse of an endotracheal tube.
All of the incidents had taken place between April 2008 and September 2009, while Mr Lockyear was practising as a locum veterinary surgeon at St Runwald's Veterinary Surgery, Colchester, Essex.
The Disciplinary Committee heard evidence from a pharmacist, Mr Noble, to whom Mr Lockyear had presented an incomplete veterinary prescription for 12 ampoules of Sustanon, a prescription-only anabolic steroid for humans, and a further pharmacist, Mr Foskett MRPharmS, who outlined his suspicions that the steroids were in fact for Mr Lockyear's personal use (Sustanon is a substance which can potentially be misused in relation to body-building). Mr Lockyear had originally claimed the drugs were for general stock at the practice; he later returned with a second prescription, for double the amount of Sustanon, claiming it was for his own dog; later again, he said the prescription was for a friend's dog.
The Committee also heard evidence from the veterinary owner of the practice, a veterinary nurse and a student veterinary nurse working in the practice team, and from Dr Maddison MRCVS, an expert on small animal clinical pharmacology. Dr Maddison informed the Committee that there was a veterinary alternative to Sustanon, so it was not necessary for that drug to have been sought by Mr Lockyear. She was also of the view that Sustanon would not have been suitable to treat the ailments for which Mr Lockyear claimed it was to be used.
The Committee found Mr Lockyear guilty of the first charge - that is attempting to obtain medicines dishonestly. Chairing the Disciplinary Committee, Mrs Alison Bruce, said: "Whilst it was a one-off incident, it is conduct which falls far short of that which is expected of a member of the profession. It involves serious dishonesty; it represents an abuse of a veterinary surgeon's authority to prescribe drugs; it is conduct which tends to undermine public trust in the profession, and the honesty of its members; it is conduct which compromised other professionals, the pharmacists involved, and undermined the trust which ought to exist between pharmacists and veterinary surgeons generally, in the important area of drug prescription." The Committee therefore directed that Mr Lockyear's name be removed from the Register.
Regarding the second charge, the Committee was most concerned about the incident relating to the dog's testicles, which it felt offended against Mr Lockyear's duty to treat with respect all animals which were his patients. Taking the three incidents as a whole, the Committee felt that Mr Lockyear should be seriously criticised for behaviour that was "unprofessional... juvenile, inappropriate, disgusting and offensive". However, they felt that the conduct was not malicious, and did not occur in the presence of a member of the public, so concluded that this did not amount to disgraceful conduct in a professional respect.
Norbrook has verified that the pH of certain batches has increased over time and is out of specification.
This issue impacts the following batches:
A spokesperson said: "There has been no increased risk to animal safety identified but we take quality extremely seriously so we initiated a voluntary recall. We have informed all of the competent authorities and we are working with our distributor to advise immediate quarantine of any remaining inventory."
If you have any questions concerning the recall, contact Ms. Anita Vanderlaan Tel: +44 (0)28 3026 4435, Email: anita.vanderlaan@norbrook.co.uk
The centres have cutting-edge facilities, including high-tech audio-visual equipment with ceiling-mounted cameras to relay demonstrations, phantom models for abdominal ultrasound training and advanced simulators for practicing echocardiography.
The courses will be taught mainly by clinicians from across the IVC Evidensia network,
IVC says the centres will deliver 20,000 hours of CPD for its staff this year, and it aims to make its training available to the broader veterinary community towards the end of 2025.
Daniella Dos Santos, Director of Professional Culture at IVC Evidensia, said: “These centres will allow us to provide tailored training, whether you’re just starting your career or you’re looking to develop new skills and techniques.
"The training will help us deliver exceptional care for pets and their owners by ensuring our colleagues and eventually the wider profession continue to grow and develop their expertise.”
It's National Veterinary Nurse Week from 26th October to 1st November and vet nurses across the country will be raising awareness of the important job they do in caring for the nation's pets. Bonny Millar CVT(USA), RVN, REVN, Vice President of the BVNA and VN week organiser has called for vets and practice managers to support the initiative.
She said: "This is an ideal opportunity for practices to use their nurses to full effect. A lot of our efforts go on behind the scenes and so nurses are sometimes not fully appreciated by pet owners. We are encouraging practices to get their nurses out at front of house, running clinics and offering clients help and expert advice. Reducing barriers and educating the wider public about the role of the vet nurse can only be a good thing. Vets and practice managers know what a great contribution a good vet nurse can make to the practice and we would love to see them make a big effort to be ‘loud and proud' during National VN Week."
Bonnie added: "Last year hundreds of veterinary nurses took part in VN Week and we raised over £5000 for charity. This year our nominated charity is the Animal Cancer Trust so I hope practices really support their nurses in helping raise money for this important cause."
The British Veterinary Nursing Association is co-ordinating the various activities going on around the country and has arranged two pet health check days in Roundhay Park in Leeds on 26th October and Kensington Gardens in London on 1st November, sponsored by Hill's Pet Nutrition. Nurses are also being encouraged to make a special effort with prizes on offer thanks to sponsors Animalcare (Satellite Navigation system), Merial (lap top) and Vetoquinol (Nintendo Wii) for the most innovative event, most public involvement and most money raised for charity.
Further information and a registration pack is available from the BVNA http://www.bvna.org.uk/ (Tel 01279 408644). Any members of the practice interested in keeping up to date with the activities planned for VN Week can also visit the blog for the event at http://vnweek.wordpress.com/
The company says the sponsorship aims to expand the inclusion of under-represented groups in veterinary education.
Peter Holland, Associate Dean for Partnerships and Enterprise in UCLan’s School of Veterinary Medicine, said: “The University has a keen focus on improving access to, and inclusion of, under-represented communities in higher education, and the new School of Veterinary Medicine holds this ethos very much at its core.
"We took a different approach to selecting students for our BVMS course as we wanted to widen participation in veterinary education by addressing some of the demographic or circumstantial barriers that have denied people the chances of learning and becoming the next generation of vets.”
“As a ‘widening participation’ sponsor, Medivet is investing significantly in UCLan’s students to enable the school to realise many of its ambitions to broaden the entry pool into veterinary higher education, and is actively supporting their development across the five years for a successful future in the profession.”
Chris Cools, CEO of Medivet, said: “Our profession needs great clinical talent for a long term, healthy and sustainable future, and we are proud to support UCLan in its ambition to attract, teach and train a new generation of veterinary students from all backgrounds.”
The first cohort of 78 BVMS students enrolled in early September, with intake numbers rising to 120 per year after two years.
The Royal College of Veterinary Surgeons is inviting comments on new proposals for bringing the Veterinary Surgeons Act 1966 up to date.
In 2005, following earlier consultations, the RCVS Council called for extensive changes in the arrangements for regulating veterinary surgeons and veterinary nurses. Last year, however, the Government made clear that it had no plans to bring forward amending legislation for the time being.
Council has now considered recommendations for more limited changes in the Act. The report of the Veterinary Legislation Group advises focusing on three priority areas: the composition of Council itself; the composition of the Preliminary Investigation and Disciplinary Committees; and the jurisdiction and powers of the two committees.
Council would welcome comments on the recommendations from veterinary surgeons and veterinary nurses, interested bodies and the public.
"We now know that it will not be easy to get any changes to the Veterinary Surgeons Act, so we need to think very carefully about the priorities and how to achieve them," says RCVS President Sandy Trees. "Before making any decisions, we want to hear views from a wide range of people who are affected by the work of the RCVS."
A consultation paper is online at www.rcvs.org.uk/consultations. Hard copies are also available from Jeff Gill, Policy Officer, RCVS, Belgravia House, 62-64 Horseferry Road, London SW1P 2AF, j.gill@rcvs.org.uk, 020 7202 0735. The deadline for responses is 21 October 2009.
The awards were:
Queen’s Medal - to Dr John (Iain) Glen MRCVS (pictured right) who, at AstraZeneca, was responsible for the discovery and development of the anaesthetic drug propofol, one of the world’s most common anaesthetics for medical and veterinary use.
Honorary Associateships - Two were awarded this year. The first went to Professor Stuart Carter, Emeritus Professor of Veterinary Pathology at the University of Liverpool’s Institution of Infection, Veterinary and Ecological Sciences. The second was awarded to Anthony Martin, a philanthropist with a particular interest in supporting national and international charities working with the veterinary profession to improve animal welfare.
Impact Award - Two were awarded this year. The first went to Alison Lambert, the founder and owner of veterinary business consultancy Onswitch which helps veterinary businesses create customer-centred practice so that pets, horses and livestock receive the best care. The second was awarded to Dr Gwenllian Rees for her involvement in the Arwain Vet Cymru (AVC) project, a collaborative national antimicrobial stewardship program for farm vets in Wales.
Inspiration Awards - Daniella Dos Santos MRCVS was nominated for her leadership role at the BVA during the early stage of the coronavirus pandemic. The second award went to Professor Mandy Peffers, a Wellcome Trust Clinical Intermediate Fellow in Musculoskeletal & Ageing Science at the Institute of Life Course and Medical Sciences at the University of Liverpool.
The International Award was posthumously awarded to Emeritus Professor Michael Day, the prolific researcher and writer.
A new award this year is the Compassion Award, which was given to David Martin MRCVS for his work helping practitioners identify the signs of non-accidental injury.
Another new award this year is the Student Community Award, given to Jack Church, who - on top of his studies - has been volunteering on a covid ward, and Lavinia Economu, for her work to inspire young people from Black, Asian and Minority Ethnic (BAME) and different socio-economic backgrounds into the veterinary professions..
Dr Mandisa Greene MRCVS, RCVS President, said: “I am so impressed by the breadth and depth of the awards nominations that we received this year which demonstrate the very best that the veterinary professions have to offer.
“From veterinary students to veterinary surgeons and nurses who have been practising for decades, all our award winners demonstrate that veterinary professionals and veterinary science has a profound and positive impact not only on animal health and welfare but also wider society. I am immensely happy and proud for them all and look forward to formally being able to present them with their awards later this year.”
A formal awards ceremony, hosted by Mandisa, will take place on Thursday, 23 September 2021. Further details on the event and how to attend will be published later this year.